Agilent Technologies, Inc. is a prominent provider of laboratory solutions focused on the life sciences, diagnostics, and applied chemical markets globally. The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. It offers a wide range of instruments and technologies, including chromatography systems, mass spectrometry, spectroscopy, and cell analysis tools, aimed at enhancing laboratory efficiency and data management. Agilent also specializes in genomic analysis, providing tools for DNA mutation detection, gene expression profiling, and quality control of nucleic acid samples. Furthermore, the Agilent CrossLab segment delivers consumables, training, and consultation services to support laboratory operations. The company markets its products via direct sales, distributors, and electronic commerce, serving diverse sectors such as biopharmaceuticals, environmental testing, forensics, and food safety. Founded in 1999 and headquartered in Santa Clara, California, Agilent Technologies continues to innovate and collaborate with various organizations to address critical scientific needs.
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.
Resolution Bioscience is pioneering next-generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy. Resolution Bioscience's proprietary molecular analytics platform interrogates cell-free DNA for actionable information that, until now, has only been accessible through invasive biopsy procedures. Resolution Bioscience has developed over 50 focused panels and is currently working on companion diagnostics to support therapeutic approvals. Resolution Bioscience is dedicated to improving cancer outcomes through a suite of clinical tests to guide the selection of targeted therapies and monitor their effectiveness over time.
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.
BioTek Instruments focuses in the manufacturing, development, and sale of life science instrumentation and software, including imaging and microscopy, multi-mode detection, liquid handling, and automation systems. The company's philosophy transcends conventional thinking and challenges the status quo. It develops fresh, original solutions by unifying concepts that often appear to be opposed. It means to shape and reshape. To engineer, build, deliver, and support products that best serve the marketplace by providing what people need, when needed.
Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation.
At Genohm we believe that every scientist deserves to organize his digital data management system according to his own needs and matching closely his own laboratory workflows. We have established our expertise in software automation solutions covering LIMS + ELN + order management. Today, a wide range of international clients such as Biobanks, research (R&D) and Next Generation Sequencing (NGS) laboratories in Universities and hospitals, as well as Biotech companies trust our SLims platform.”
LaserGen, Inc., a biotechnology company, engages in the development and commercialization of technologies for genomics application. It develops various technologies for sequencing applications. The company's products detect heritable and somatic sequence variations in the human genome for use as diagnostics tools for the management of diseases. LaserGen, Inc. was incorporated in 2002 and is based in Houston, Texas.
Luxcel Biosciences was founded in 2002 in Co. Cork, Ireland, to commercialise cutting-edge, porphyrin-based, phosphorescent, oxygen-sensing probes and oxygen sensors, with initial applications targeted at the pharmaceutical, food safety and packaging industries. Our aim at Luxcel Biosciences is to produce fluorescence and phosphorescence-based tools that will provide direct benefits for our customers. These benefits include increased speed and accuracy, reduced research and development (R&D) costs for manufacturers, and safer products for consumers.
NanoCellect Biomedical develops and delivers microfluidic-based solutions that are affordable, compact, and easy to use. Its expanding portfolio of instruments and consumables enables biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, antibody discovery, and basic research.
LaserGen, Inc., a biotechnology company, engages in the development and commercialization of technologies for genomics application. It develops various technologies for sequencing applications. The company's products detect heritable and somatic sequence variations in the human genome for use as diagnostics tools for the management of diseases. LaserGen, Inc. was incorporated in 2002 and is based in Houston, Texas.
Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers.
BioSystem Development creates, manufactures, and markets system products for unmet needs in the fields of biotechnology and life science research.
Lab901
Acquisition in 2011
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.
BIOCIUS Life Sciences, Inc. engages in the drug discovery research. The company was incorporated in 2009 and is based in Woburn, Massachusetts. BIOCIUS Life Sciences, Inc. operates as a subsidiary of BioTrove, Inc.
Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.
SynPro
Acquisition in 2006
SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.